GlaxoSmithKlins (GSK) and Amicus Therapeutics (FOLD) Announces Amigal Collaboration' Amicus to Receive $30M Upfront, $170M in Potential Milestones

Go back to GlaxoSmithKlins (GSK) and Amicus Therapeutics (FOLD) Announces Amigal Collaboration' Amicus to Receive $30M Upfront, $170M in Potential Milestones
Amicus Therapeutics, Inc. (NASDAQ: FOLD) Delayed: 14.49 --0 (-0%)
Previous Close $14.49    52 Week High $11.78 
Open $14.49    52 Week Low $4.98 
Day High $14.49    P/E N/A 
Day Low $14.49    EPS $-1.15 
Volume 561,059       

GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 50.10 +0.58 (1.17%)
Previous Close $49.52    52 Week High $45.58 
Open $49.93    52 Week Low $37.82 
Day High $50.37    P/E N/A 
Day Low $49.88    EPS $0.00 
Volume 1,397,192